Growth Metrics

Q32 Bio (QTTB) FCF Margin (2018 - 2023)

Historic FCF Margin for Q32 Bio (QTTB) over the last 6 years, with Q4 2023 value amounting to 796.32%.

  • Q32 Bio's FCF Margin rose 41888400.0% to 796.32% in Q4 2023 from the same period last year, while for Sep 2024 it was 4979.34%, marking a year-over-year increase of 53818900.0%. This contributed to the annual value of 287.16% for FY2023, which is 32959400.0% up from last year.
  • According to the latest figures from Q4 2023, Q32 Bio's FCF Margin is 796.32%, which was up 41888400.0% from 849.38% recorded in Q3 2023.
  • Over the past 5 years, Q32 Bio's FCF Margin peaked at 849.38% during Q3 2023, and registered a low of 10495.19% during Q1 2019.
  • For the 5-year period, Q32 Bio's FCF Margin averaged around 3265.99%, with its median value being 3614.46% (2021).
  • Per our database at Business Quant, Q32 Bio's FCF Margin tumbled by -94253000bps in 2019 and then surged by 57538600bps in 2020.
  • Over the past 5 years, Q32 Bio's FCF Margin (Quarter) stood at 5338.9% in 2019, then skyrocketed by 76bps to 1282.35% in 2020, then tumbled by -199bps to 3836.41% in 2021, then rose by 12bps to 3392.52% in 2022, then soared by 123bps to 796.32% in 2023.
  • Its FCF Margin stands at 796.32% for Q4 2023, versus 849.38% for Q3 2023 and 357.07% for Q2 2023.